How to treat and prevent eosinophil-mediated diseases in combination with Pap antagonists and measure their efficacy

摘要

FIELD OF THE INVENTION The present invention relates to the treatment and prevention of eosinophil-mediated diseases as pap antagonists and to methods for measuring their efficacy. In combination with a paid amount of at least one pape antagonist to treat and prevent diseases caused by eosinophils in accordance with the present invention, the subjects are administered to a subject in need of such treatment for allergy and inflammation, and the pape antagonists are hydrophilic or non-hydrophilic Azolezioen-diazepines or their analogs, gingkolides, gingkolide mixtures or synthetic gingkolide derivatives, or homologs of pape or mixtures of these compounds.